PLATINUM2023

INSULIN FOR LIFE USA INC

Gainesville, FL   |  www.ifl-usa.org

Mission

To provide free of charge insulin and disease management supplies to those with diabetes who otherwise would go without these life saving provisions. In short, the organization collects in date, unopened, supplies from individuals or organizations in the USA and, following careful inspection, delivers them to disadvantaged regions to be utilized by those in need. IFL-USA is fully licensed by the State of Florida to both receive and distribute medications for this purpose, and is insured for its activities. All donations to the organization are tax deductible in accordance with regulations.

Ruling year info

2012

President

Dr. Mark Atkinson

Vice President

Dr. Francine Kaufman M.D.

Main address

2555 SW 76th Street 130

Gainesville, FL 32608 USA

Show more contact info

EIN

46-0771608

NTEE code info

International Relief (Q33)

Specifically Named Diseases (G80)

Health Support Services (E60)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2020, 2019 and 2018.
Register now

Communication

Programs and results

What we aim to solve

This profile needs more info.

If it is your nonprofit, add a problem overview.

Login and update

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Collect and redistribute insulin and diabetes supplies

Insulin for Life USA (IFL-USA) is a non-profit, 501(c)3 organization whose purpose is to provide, free of cost, medications and disease management supplies to people with diabetes who would otherwise go without these life-saving provisions. In brief, the organization gathers in-date, unopened, and otherwise unneeded supplies from people with diabetes in the USA, their family members, or organizations (e.g., clinics, manufacturers, pharmacies) and, after careful inspection, delivers them to clinics to benefit those in need. IFL-USA is fully licensed by the State of Florida to both receive and distribute medications for this purpose. To be clear, IFL-USA does not offer supplies directly to individuals, but only to medical professionals that have been thoroughly vetted for their professional character and dedication to charity-based care.

Population(s) Served
Adults
Children and youth
People with diseases and illnesses

To provide free of charge insulin and disease management supplies to those with diabetes who otherwise would go without these life-saving provisions. In short, the organization collects in date, unopened, supplies from individuals or organizations in the USA and, following careful inspection, delivers them to disadvantaged regions to be utilized by those in need. IFL-USA is fully licensed by the State of Florida to both receive and distribute medications for this purpose and is insured for its activities. All donations to the organization are tax-deductible in accordance with regulations.

Population(s) Served
Adults
Health
Children and youth

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Units of insulin distributed

This metric is no longer tracked.
Totals By Year
Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Context Notes

2022 Distributions: • 173,202 mL of insulin (17,320,200 units) • 655,000 test strips • 4,707 glucometers/CGM receivers • 173 Hypo kits • 556,819 insulin syringes • 826,101 pen needles • 529,375 lancet

Number of test strips distributed

This metric is no longer tracked.
Totals By Year
Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

Given the need, as an organization, Insulin for Life USA has a number of key goals. First amongst them, our desire is to save lives….as many as possible. It has been estimated that nearly 95,000 children with type 1 diabetes, from some 45 countries, lack in having continued access to insulin. Second, our organization is “green"; meaning, we seek to reduce and eventually eliminate the unnecessary waste of viable insulin and diabetes supplies. For a variety of reasons (e.g., prescription change, pharmaceutical error, death of a family member with diabetes), insulin or other diabetes supplies become available and are normally subject to disposal. Our desire is to turn what would form medical waste into a life saving gift. Third, as a not for profit, we must build sustainability and with this, seek the support (both financial and in-kind donations) from a diverse population of supporters including individuals, pharmaceutical companies, medical device manufacturers, and charitable organizations interested in global health care. Finally, we place major emphasis on raising public awareness of the problem as well as increasing governmental health care agency contributions to the care and treatment of those with the disease.

IFL USA solicits donations of diabetes supplies that are in-date, unopened, and suitable for utilization. The items are carefully vetted and inventoried for redistribution. IFL USA partners with licensed healthcare providers worldwide. The supplies are then redistributed to our partner healthcare teams for their needy patients.

IFL USA is a registered business in the State of Florida. IFL USA is an actively approved 501(c)3 organization. IFL USA holds a Florida Drug License, which authorizes it's organizational activities.

IFL USA has made significant progress in distributing diabetes supplies worldwide. We can share the following data to reflect our progress in the calendar year 2022.

International Partners – 25 programs in 23 countries
Domestic Partners – 52 programs

2022 Distributions:
• 173,202 mL of insulin (17,320,200 units)
• 655,000 test strips
• 4,707 glucometers/CGM receivers
• 173 Hypo kits
• 556,819 insulin syringes
• 826,101 pen needles
• 529,375 lancets
• 4,167 lancing devices

(Valued at $7,824,951 US)

Financials

INSULIN FOR LIFE USA INC
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

INSULIN FOR LIFE USA INC

Board of directors
as of 05/08/2023
SOURCE: Self-reported by organization
Board chair

Dr. Mark Atkinson

University of Florida

Mark Atkinson

The University of Florida

Francine Kaufman

Senseonics

Margery Perry

Howard Steinberg

Westport Innovation HUB

Howard Anhalt

Howard Halligan

Health Monitor

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 5/8/2023
info Candid has made improvements to the race and ethnicity options.

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Male, Not transgender (cisgender)
Sexual orientation
Heterosexual or straight
Disability status
Person without a disability

The organization's co-leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female
Sexual orientation
Heterosexual or straight
Disability status
Person without a disability

Race & ethnicity

No data

Gender identity

 

Sexual orientation

No data

Disability

No data

Equity strategies

Last updated: 05/08/2023

GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more

Data
  • We review compensation data across the organization (and by staff levels) to identify disparities by race.
  • We ask team members to identify racial disparities in their programs and / or portfolios.
  • We analyze disaggregated data and root causes of race disparities that impact the organization's programs, portfolios, and the populations served.
  • We disaggregate data to adjust programming goals to keep pace with changing needs of the communities we support.
  • We have long-term strategic plans and measurable goals for creating a culture such that one’s race identity has no influence on how they fare within the organization.
Policies and processes
  • We have a promotion process that anticipates and mitigates implicit and explicit biases about people of color serving in leadership positions.
  • We seek individuals from various race backgrounds for board and executive director/CEO positions within our organization.
  • We have community representation at the board level, either on the board itself or through a community advisory board.